Barrow, Hanley, Mewhinney & Strauss’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
Other funds holding HOLX
Barrow, Hanley, Mewhinney & Strauss's HOLX Position: Q2 2023 in Review
Barrow, Hanley, Mewhinney & Strauss sold out of Hologic (HOLX) in Q2 2023, closing a stake of 1,065,151 shares — an estimated $86M sold.
Barrow, Hanley, Mewhinney & Strauss first reported a position in HOLX in Q1 2020 and held it in 13 quarters. The position peaked at $186M in Q3 2021. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.
- Barrow, Hanley, Mewhinney & Strauss reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
- Barrow, Hanley, Mewhinney & Strauss sold 1,065,151 Hologic shares in Q2 2023, an estimated $86M.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Hologic in Q1 2020 and held it in 13 quarters.
- Barrow, Hanley, Mewhinney & Strauss's Hologic position peaked at $186M in Q3 2021.
- 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2023, filed 10 Aug 2023.